Cellebrite DI Ltd.
CLBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $126,029 | $113,276 | $107,549 | $109,049 |
| % Growth | 11.3% | 5.3% | -1.4% | – |
| Cost of Goods Sold | $20,314 | $17,677 | $17,490 | $17,624 |
| Gross Profit | $105,715 | $95,599 | $90,059 | $91,425 |
| % Margin | 83.9% | 84.4% | 83.7% | 83.8% |
| R&D Expenses | $28,124 | $28,611 | $27,277 | $25,599 |
| G&A Expenses | $19,801 | $13,886 | $11,746 | $14,575 |
| SG&A Expenses | $58,601 | $52,571 | $50,514 | $50,099 |
| Sales & Mktg Exp. | $38,800 | $38,685 | $38,768 | $35,524 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $86,725 | $81,182 | $77,791 | $75,698 |
| Operating Income | $18,990 | $14,417 | $12,268 | $15,727 |
| % Margin | 15.1% | 12.7% | 11.4% | 14.4% |
| Other Income/Exp. Net | $5,298 | $6,374 | $7,060 | $4,170 |
| Pre-Tax Income | $24,288 | $20,791 | $19,328 | $19,897 |
| Tax Expense | $4,099 | $1,315 | $1,928 | $628 |
| Net Income | $20,189 | $19,476 | $17,400 | $19,269 |
| % Margin | 16% | 17.2% | 16.2% | 17.7% |
| EPS | 0.083 | 0.081 | 0.07 | 0.083 |
| % Growth | 2.3% | 15.7% | -15.3% | – |
| EPS Diluted | 0.08 | 0.078 | 0.07 | 0.078 |
| Weighted Avg Shares Out | 252,366 | 240,359 | 248,575 | 233,248 |
| Weighted Avg Shares Out Dil | 249,720 | 248,980 | 249,302 | 247,354 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,298 | $6,374 | $7,060 | $4,170 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | $2,703 | $2,592 | $2,631 | $2,729 |
| EBITDA | $26,991 | $17,009 | $14,899 | $18,456 |
| % Margin | 21.4% | 15% | 13.9% | 16.9% |